Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senior Senators Seek Details On Government Audits Of 340B Entities

This article was originally published in The Pink Sheet Daily

Executive Summary

Top Republicans on two Senate health committees are joined by House members in seeking answers on an HHS review of entities receiving 340B drug discounts, including the process and consequences of audits and decertification.

You may also be interested in...



Hatch, Alexander Expected To Helm Health Panels In Senate

Orrin Hatch, the supplement industry’s chief congressional ally and veteran of major pharmaceutical legislative initiatives, is in line to head the Finance Committee with Republican control of the Senate. The HELP Committee – with jurisdiction over public health – could be Lamar Alexander’s first chair opportunity.

Hatch, Alexander Expected To Helm Health Panels In Senate

Orrin Hatch, the supplement industry’s chief congressional ally and veteran of major pharmaceutical legislative initiatives, is in line to head the Finance Committee with Republican control of the Senate. The HELP Committee – with jurisdiction over public health – could be Lamar Alexander’s first chair opportunity.

Sens. Hatch, Alexander Expected To Helm Health Panels In Senate

Orrin Hatch, the veteran of major pharmaceutical legislative initiatives, is in line to head the Finance Committee with the change to Republican control of the Senate. The Health, Education, Labor and Pensions Committee – with jurisdiction over biomedical R&D and public health – will be headed by Lamar Alexander, in his first opportunity to chair a committee.

Related Content

Topics

UsernamePublicRestriction

Register

PS075357

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel